To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain per

What happened?

Proposal in Congress

  1. Introduced in House
Read the details

What this means

Status
Proposal in Congress
Latest action
Referred to the House Committee on Energy and Commerce.
What to check next
The bill was sent to the House Committee on Energy and Commerce for consideration.
Check the original record

Record details

Bill number
H.R. 1051
Congress
119
Introduced
2025-02-06
Sponsor
Rep. Budzinski, Nikki [D-IL-13]
Committees
Energy and Commerce Committee
Latest documented action
Referred to the House Committee on Energy and Commerce.

Documented actions

  1. Referred to the House Committee on Energy and Commerce.

  2. Introduced in House

  3. Introduced in House

Sources and related records

Source checked .